Supplementary Materials and Methods from CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen,Pan Tong,C. Allison Stewart,Sandra Cristea,Aly Valliani,David S. Shames,Abena B. Redwood,You Hong Fan,Lerong Li,Bonnie S. Glisson,John D. Minna,Julien Sage,Don L. Gibbons,Helen Piwnica-Worms,John V. Heymach,Jing Wang,Lauren Averett Byers

crossref（2023）

引用 0|浏览51

暂无评分

摘要

This file contains additional details of materials and methods used in this study like SCLC cell line authentication, targeted knockdown of CHK1 and MYC, PCR, cell viability aasay, cell cycle analysis, generation of tumor models, RPPA and immunofluorescence.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要